ORGANOGENESIS HOLDINGS INC. Accounts Receivable, Allowance for Credit Loss
ORGANOGENESIS HOLDINGS INC. (ORGO) had Accounts Receivable, Allowance for Credit Loss of $9.95 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2026-08-06
- 2026-06-30: Accounts Receivable, Allowance for Credit Loss $9.95M.
- 2026-03-31: Accounts Receivable, Allowance for Credit Loss $11.49M.
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss $16.09M.
- 2025-09-30: Accounts Receivable, Allowance for Credit Loss $13.44M.
| Period end | Accounts Receivable, Allowance for Credit Loss | Accounts Receivable, Allowance for Credit Loss as first filed |
|---|---|---|
| 2026-06-30 | $9.95M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $11.49M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $16.09M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $13.44M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $11.15M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $9.07M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $9.58M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $9.73M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $8.51M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $7.47M 10-Q · filed 2025-08-07 | |
| 2023-12-31 | $6.86M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $7.55M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $6.65M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $6.92M 10-Q · filed 2024-08-08 | |
| 2022-12-31 | $6.36M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $5.58M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $5.02M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $5.13M 10-Q · filed 2023-08-09 | |
| 2021-12-31 | $5.15M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $4.53M 10-Q · filed 2022-11-09 | $7.34M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $4.13M 10-Q · filed 2022-11-09 | $7.11M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $3.58M 10-Q · filed 2022-08-09 | $6.08M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $2.67M 10-K · filed 2023-03-01 | $4.99M 10-K · filed 2021-03-16 |
| 2020-09-30 | $5.13M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $3.93M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $3.20M 10-Q · filed 2021-08-09 | |
| 2019-12-31 | $1.99M 10-K · filed 2022-03-01 | $3.05M 10-K · filed 2020-03-09 |
| 2019-09-30 | $2.94M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $3.02M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $3.29M 10-Q · filed 2020-08-10 | |
| 2018-12-31 | $3.42M 10-Q · filed 2020-11-09 | |
| 2018-09-30 | $3.09M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $2.85M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $2.96M 10-Q · filed 2019-08-09 | |
| 2017-12-31 | $3.42M 10-K · filed 2021-03-16 | $3.23M 10-K · filed 2019-03-18 |
| 2016-12-31 | $2.11M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |